WallStreetZenWallStreetZen

NASDAQ: EQ
Equillium Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for EQ

Based on 3 analysts offering 12 month price targets for Equillium Inc

Min Forecast
$6.00+239.94%
Avg Forecast
$8.00+353.26%
Max Forecast
$12.00+579.89%

Should I buy or sell EQ stock?

Based on 3 analysts offering ratings for Equillium Inc.

Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although EQ's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates EQ as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their EQ stock forecasts and price targets.

EQ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-17
lockedlocked$00.00+00.00%2026-04-16
lockedlocked$00.00+00.00%2026-04-14

1 of 1

Forecast return on equity

Is EQ forecast to generate an efficient return?

Company
-38.04%
Industry
86.04%
Market
174.48%
EQ's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EQ forecast to generate an efficient return on assets?

Company
-35.87%
Industry
29.83%
EQ is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EQ earnings per share forecast

What is EQ's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$0.23
Avg 2 year Forecast
-$0.26
Avg 3 year Forecast
-$0.32

EQ revenue forecast

What is EQ's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

EQ vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EQ$1.77$8.00+353.26%Strong Buy
KLRS$4.70$18.75+298.94%Strong Buy
NRXP$3.03$38.25+1,162.38%Strong Buy
RANI$0.88$8.00+804.98%Strong Buy
MSLE$6.99$18.00+157.51%Strong Buy
View Top Biotech Stocks

Equillium Stock Forecast FAQ

Is Equillium Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: EQ) stock is to Strong Buy EQ stock.

Out of 3 analysts, 3 (100%) are recommending EQ as a Strong Buy, 0 (0%) are recommending EQ as a Buy, 0 (0%) are recommending EQ as a Hold, 0 (0%) are recommending EQ as a Sell, and 0 (0%) are recommending EQ as a Strong Sell.

If you're new to stock investing, here's how to buy Equillium stock.

What is EQ's earnings growth forecast for 2026-2028?

(NASDAQ: EQ) Equillium's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.11%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.32%.

Equillium's earnings in 2026 is -$19,055,000.On average, 11 Wall Street analysts forecast EQ's earnings for 2026 to be -$14,232,298, with the lowest EQ earnings forecast at -$17,968,987, and the highest EQ earnings forecast at -$11,949,819. On average, 11 Wall Street analysts forecast EQ's earnings for 2027 to be -$16,653,875, with the lowest EQ earnings forecast at -$26,643,671, and the highest EQ earnings forecast at -$13,277,577.

In 2028, EQ is forecast to generate -$20,080,754 in earnings, with the lowest earnings forecast at -$27,882,911 and the highest earnings forecast at -$15,269,213.

What is EQ's revenue growth forecast for 2026-2028?

(NASDAQ: EQ) Equillium's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.37%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.15%.

Equillium's revenue in 2026 is $0.On average, 9 Wall Street analysts forecast EQ's revenue for 2026 to be $0, with the lowest EQ revenue forecast at $0, and the highest EQ revenue forecast at $0. On average, 8 Wall Street analysts forecast EQ's revenue for 2027 to be $0, with the lowest EQ revenue forecast at $0, and the highest EQ revenue forecast at $0.

In 2028, EQ is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is EQ's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: EQ) forecast ROA is -35.87%, which is lower than the forecast US Biotechnology industry average of 29.83%.

What is EQ's Price Target?

According to 3 Wall Street analysts that have issued a 1 year EQ price target, the average EQ price target is $8.00, with the highest EQ stock price forecast at $12.00 and the lowest EQ stock price forecast at $6.00.

On average, Wall Street analysts predict that Equillium's share price could reach $8.00 by Apr 17, 2027. The average Equillium stock price prediction forecasts a potential upside of 353.26% from the current EQ share price of $1.77.

What is EQ's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: EQ) Equillium's current Earnings Per Share (EPS) is -$0.26. On average, analysts forecast that EQ's EPS will be -$0.23 for 2026, with the lowest EPS forecast at -$0.28, and the highest EPS forecast at -$0.19. On average, analysts forecast that EQ's EPS will be -$0.26 for 2027, with the lowest EPS forecast at -$0.42, and the highest EPS forecast at -$0.21. In 2028, EQ's EPS is forecast to hit -$0.32 (min: -$0.44, max: -$0.24).

What is EQ's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: EQ) forecast ROE is -38.04%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.